Does age affect the response to zinc therapy for diarrhoea in Bangladeshi infants?

Christa L. Fischer Walker, Robert E. Black, Abdullah H. Baqui

Research output: Contribution to journalArticlepeer-review

Abstract

The benefit of zinc for the treatment of diarrhoea in a duster-randomized trial of children, aged 3-59 months, living in rural Bangladesh was previously reported. Here, the benefits of zinc stratified by age - 3-5 months, 6-11 months, and 12-59 months - are reported. Although the sample sizes in the stratified groups were too small to detect statistical significance in the 3-5-month and 6-11-month age-groups, the trends suggest that there may be a benefit of zinc for the treatment of diarrhoea on the duration of diarrhoea and on subsequent morbidity and mortality. Additional research is needed to better understand the effect of zinc for the treatment of diarrhoea among infants aged less than six months.

Original languageEnglish (US)
Pages (from-to)105-109
Number of pages5
JournalJournal of Health, Population and Nutrition
Volume26
Issue number1
StatePublished - Mar 1 2008

Keywords

  • Age factor
  • Bangladesh
  • Child
  • Cluster randomized trials
  • Community-based studies
  • Diarrhoea
  • Infant
  • Infantile
  • Zinc
  • Zinc supplementation
  • Zinc therapy

ASJC Scopus subject areas

  • Food Science
  • Public Health, Environmental and Occupational Health
  • Health, Toxicology and Mutagenesis

Fingerprint

Dive into the research topics of 'Does age affect the response to zinc therapy for diarrhoea in Bangladeshi infants?'. Together they form a unique fingerprint.

Cite this